Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
M

MDT

NYSE

Medtronic plc

Latest disclosureSeptember 17, 2026
Insider score Why 0?
0/ 100
Qualifying buys · 30d
$0

0 purchases · 4 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 78

Limited filing history
All78Buying0Selling4Other74
Filters

Last 30 daysNo qualifying insider buying. Sales: $138.88K by 1 insider.

78 trades · April 27, 2026 – September 16, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 78 trades on this page.

Sale disclosed

Harry Skip Kiil

EVP & President Cardiovascular

Ordinary Shares

Reported value
$138.88K
Reported price
$93.65 / share
Traded September 16, 2026Filed September 17, 2026SEC filing
Gift disclosed

Denise L. Blomquist

Chief Accounting Officer

Ordinary Shares

Value context
Not a purchase
Reported price
Gift · no purchase price
Understand this price

The filing reports a zero transaction price for this gift. It does not establish the market value of the gift.

Traded September 15, 2026Filed September 16, 2026SEC filing
Tax or exercise withholding

Michael Marinaro

EVP, Pres MedSurg and Americas

Ordinary Shares

Value context
$100.05K
Reported price
$92.30 / share
Traded August 20, 2026Filed August 24, 2026SEC filing
Tax or exercise withholding

Denise L. Blomquist

Chief Accounting Officer

Ordinary Shares

Value context
$18.1K
Reported price
$85.39 / share
Traded July 31, 2026Filed August 4, 2026SEC filing
Award disclosed

Denise L. Blomquist

Chief Accounting Officer

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Award disclosed

Denise L. Blomquist

Chief Accounting Officer

Performance Share Units

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Award disclosed

Denise L. Blomquist

Chief Accounting Officer

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Tax or exercise withholding

Matthew R. Walter

SVP, Chief HR Officer

Ordinary Shares

Value context
$143.03K
Reported price
$85.39 / share
Traded July 31, 2026Filed August 4, 2026SEC filing
Award disclosed

Matthew R. Walter

SVP, Chief HR Officer

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Award disclosed

Matthew R. Walter

SVP, Chief HR Officer

Performance Share Units

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Award disclosed

Matthew R. Walter

SVP, Chief HR Officer

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Tax or exercise withholding

Kweli Thompson

EVP & President, Neuroscience

Ordinary Shares

Value context
$148.49K
Reported price
$85.39 / share
Traded July 31, 2026Filed August 4, 2026SEC filing
Award disclosed

Kweli Thompson

EVP & President, Neuroscience

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Award disclosed

Kweli Thompson

EVP & President, Neuroscience

Performance Share Units

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Award disclosed

Kweli Thompson

EVP & President, Neuroscience

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Award disclosed

Michelle Quinn

EVP, GC and Secretary

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Award disclosed

Michelle Quinn

EVP, GC and Secretary

Performance Share Units

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Award disclosed

Michelle Quinn

EVP, GC and Secretary

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Award disclosed

Thierry Pieton

EVP & Chief Financial Officer

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Award disclosed

Thierry Pieton

EVP & Chief Financial Officer

Performance Share Units

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Award disclosed

Thierry Pieton

EVP & Chief Financial Officer

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Tax or exercise withholding

Michael Marinaro

EVP, Pres MedSurg and Americas

Ordinary Shares

Value context
$286.57K
Reported price
$85.39 / share
Traded July 31, 2026Filed August 4, 2026SEC filing
Award disclosed

Michael Marinaro

EVP, Pres MedSurg and Americas

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Award disclosed

Michael Marinaro

EVP, Pres MedSurg and Americas

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Award disclosed

Michael Marinaro

EVP, Pres MedSurg and Americas

Performance Share Units

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Award disclosed

Michael Marinaro

EVP, Pres MedSurg and Americas

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Tax or exercise withholding

Harry Skip Kiil

EVP & President Cardiovascular

Ordinary Shares

Value context
$262.49K
Reported price
$85.39 / share
Traded July 31, 2026Filed August 4, 2026SEC filing
Award disclosed

Harry Skip Kiil

EVP & President Cardiovascular

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Award disclosed

Harry Skip Kiil

EVP & President Cardiovascular

Performance Share Units

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Award disclosed

Harry Skip Kiil

EVP & President Cardiovascular

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Tax or exercise withholding

Geoffrey Martha

Chairman and CEO

Ordinary Shares

Value context
$1.35M
Reported price
$85.39 / share
Traded July 31, 2026Filed August 4, 2026SEC filing
Award disclosed

Geoffrey Martha

Chairman and CEO

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Award disclosed

Geoffrey Martha

Chairman and CEO

Performance Share Units

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Award disclosed

Geoffrey Martha

Chairman and CEO

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Award disclosed

Geoffrey Martha

Chairman and CEO

Stock Option (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded August 3, 2026Filed August 4, 2026SEC filing
Tax or exercise withholding

Michelle Quinn

EVP, GC and Secretary

Ordinary Shares

Value context
$179.75K
Reported price
$86.88 / share
Traded July 28, 2026Filed July 29, 2026SEC filing
Sale disclosed

Matthew R. Walter

SVP, Chief HR Officer

Ordinary Shares

Reported value
$257.93K
Reported price
$83.15 / share
Traded July 8, 2026Filed July 9, 2026SEC filing
Sale disclosed

Harry Skip Kiil

EVP & President Cardiovascular

Ordinary Shares

Reported value
$318.62K
Reported price
$80.44 / share
Traded June 8, 2026Filed June 9, 2026SEC filing
Sale disclosed

Harry Skip Kiil

EVP & President Cardiovascular

Ordinary Shares

Reported value
$18.34K
Reported price
$80.45 / share
Traded June 8, 2026Filed June 9, 2026SEC filing
Tax or exercise withholding

Harry Skip Kiil

EVP & President Cardiovascular

Ordinary Shares

Value context
$567.99K
Reported price
$83.32 / share
Traded June 4, 2026Filed June 8, 2026SEC filing
Tax or exercise withholding

Geoffrey Martha

Chairman and CEO

Ordinary Shares

Value context
$3.49M
Reported price
$83.32 / share
Traded June 4, 2026Filed June 8, 2026SEC filing
Tax or exercise withholding

Michael Marinaro

EVP, Pres MedSurg and Americas

Ordinary Shares

Value context
$622.48K
Reported price
$83.32 / share
Traded June 4, 2026Filed June 8, 2026SEC filing
Tax or exercise withholding

Matthew R. Walter

SVP, Chief HR Officer

Ordinary Shares

Value context
$236.63K
Reported price
$83.32 / share
Traded June 4, 2026Filed June 8, 2026SEC filing
Tax or exercise withholding

Denise L. Blomquist

Chief Accounting Officer

Ordinary Shares

Value context
$19.75K
Reported price
$83.32 / share
Traded June 5, 2026Filed June 8, 2026SEC filing
Exercise or conversion

Matthew R. Walter

SVP, Chief HR Officer

Ordinary Shares

Value context
Not established
Reported price
$0 reported · see filing
Understand this price

The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.

Traded May 26, 2026Filed May 28, 2026SEC filing
Exercise or conversion

Matthew R. Walter

SVP, Chief HR Officer

Performance Share Unit

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded May 26, 2026Filed May 28, 2026SEC filing
Exercise or conversion

Brett A. Wall

EVP & Pres Neuroscience

Ordinary Shares

Value context
Not established
Reported price
$0 reported · see filing
Understand this price

The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.

Traded May 26, 2026Filed May 28, 2026SEC filing
Exercise or conversion

Brett A. Wall

EVP & Pres Neuroscience

Performance Share Unit

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded May 26, 2026Filed May 28, 2026SEC filing
Exercise or conversion

Geoffrey Martha

Chairman and CEO

Ordinary Shares

Value context
Not established
Reported price
$0 reported · see filing
Understand this price

The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.

Traded May 26, 2026Filed May 28, 2026SEC filing
Exercise or conversion

Geoffrey Martha

Chairman and CEO

Performance Share Unit

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded May 26, 2026Filed May 28, 2026SEC filing
Exercise or conversion

Michael Marinaro

EVP, Pres MedSurg and Americas

Ordinary Shares

Value context
Not established
Reported price
$0 reported · see filing
Understand this price

The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.

Traded May 26, 2026Filed May 28, 2026SEC filing
Exercise or conversion

Michael Marinaro

EVP, Pres MedSurg and Americas

Performance Share Unit

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded May 26, 2026Filed May 28, 2026SEC filing
Exercise or conversion

Harry Skip Kiil

EVP & President Cardiovascular

Ordinary Shares

Value context
Not established
Reported price
$0 reported · see filing
Understand this price

The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.

Traded May 26, 2026Filed May 28, 2026SEC filing
Exercise or conversion

Harry Skip Kiil

EVP & President Cardiovascular

Performance Share Unit

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded May 26, 2026Filed May 28, 2026SEC filing
Exercise or conversion

Denise L. Blomquist

Chief Accounting Officer

Ordinary Shares

Value context
Not established
Reported price
$0 reported · see filing
Understand this price

The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.

Traded May 26, 2026Filed May 28, 2026SEC filing
Exercise or conversion

Denise L. Blomquist

Chief Accounting Officer

Performance Share Unit

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded May 26, 2026Filed May 28, 2026SEC filing
Tax or exercise withholding

Matthew R. Walter

SVP, Chief HR Officer

Ordinary Shares

Value context
$2.8K
Reported price
$80.00 / share
Traded May 1, 2026Filed May 4, 2026SEC filing
Award disclosed

Denise L. Blomquist

Chief Accounting Officer

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 27, 2026Filed April 29, 2026SEC filing
Tax or exercise withholding

Denise L. Blomquist

Chief Accounting Officer

Ordinary Shares

Value context
$26.04K
Reported price
$81.90 / share
Traded April 28, 2026Filed April 29, 2026SEC filing
Award disclosed

Kendall J. Powell

Director

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 27, 2026Filed April 29, 2026SEC filing
Tax or exercise withholding

Kendall J. Powell

Director

Ordinary Shares

Value context
$16.95K
Reported price
$81.90 / share
Traded April 28, 2026Filed April 29, 2026SEC filing
Award disclosed

Elizabeth G. Nabel

Director

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 27, 2026Filed April 29, 2026SEC filing
Tax or exercise withholding

Elizabeth G. Nabel

Director

Ordinary Shares

Value context
$16.95K
Reported price
$81.90 / share
Traded April 28, 2026Filed April 29, 2026SEC filing
Award disclosed

Kevin E. Lofton

Director

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 27, 2026Filed April 29, 2026SEC filing
Tax or exercise withholding

Kevin E. Lofton

Director

Ordinary Shares

Value context
$16.95K
Reported price
$81.90 / share
Traded April 28, 2026Filed April 29, 2026SEC filing
Award disclosed

Gregory P. Lewis

Director

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 27, 2026Filed April 29, 2026SEC filing
Tax or exercise withholding

Gregory P. Lewis

Director

Ordinary Shares

Value context
$16.95K
Reported price
$81.90 / share
Traded April 28, 2026Filed April 29, 2026SEC filing
Award disclosed

Joon Sup Lee

Director

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 27, 2026Filed April 29, 2026SEC filing
Award disclosed

William R. Jellison

Director

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 27, 2026Filed April 29, 2026SEC filing
Award disclosed

Randall J. Hogan

Director

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 27, 2026Filed April 29, 2026SEC filing
Tax or exercise withholding

Randall J. Hogan

Director

Ordinary Shares

Value context
$16.95K
Reported price
$81.90 / share
Traded April 28, 2026Filed April 29, 2026SEC filing
Award disclosed

John P. Groetelaars

Director

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 27, 2026Filed April 29, 2026SEC filing
Award disclosed

Lidia Fonseca

Director

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 27, 2026Filed April 29, 2026SEC filing
Tax or exercise withholding

Lidia Fonseca

Director

Ordinary Shares

Value context
$16.95K
Reported price
$81.90 / share
Traded April 28, 2026Filed April 29, 2026SEC filing
Award disclosed

Scott C. Donnelly

Director

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 27, 2026Filed April 29, 2026SEC filing
Tax or exercise withholding

Scott C. Donnelly

Director

Ordinary Shares

Value context
$16.95K
Reported price
$81.90 / share
Traded April 28, 2026Filed April 29, 2026SEC filing
Award disclosed

Craig Arnold

Director

Ordinary Shares

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded April 27, 2026Filed April 29, 2026SEC filing
Tax or exercise withholding

Craig Arnold

Director

Ordinary Shares

Value context
$16.95K
Reported price
$81.90 / share
Traded April 28, 2026Filed April 29, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
EVP & President CardiovascularOrdinary SharesSale1,483$93.65 / share$138.88KSep 16Filed Sep 17 · 1d laterSEC filing
Chief Accounting OfficerOrdinary SharesGift600Gift · no purchase priceNot a purchaseSep 15Filed Sep 16 · 1d laterSEC filing
EVP, Pres MedSurg and AmericasOrdinary SharesExercise-price or tax withholding1,084$92.30 / share$100.05KAug 20Filed Aug 24 · 4d laterSEC filing
Chief Accounting OfficerOrdinary SharesExercise-price or tax withholding212$85.39 / share$18.1KJul 31Filed Aug 4 · 4d laterSEC filing
Chief Accounting OfficerOrdinary SharesGrant or award2,337Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
Chief Accounting OfficerPerformance Share UnitsGrant or awardDerivative units2,337Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
Chief Accounting OfficerStock Option (Right to Buy)Grant or awardDerivative units1,366Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
SVP, Chief HR OfficerOrdinary SharesExercise-price or tax withholding1,675$85.39 / share$143.03KJul 31Filed Aug 4 · 4d laterSEC filing
SVP, Chief HR OfficerOrdinary SharesGrant or award5,769Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
SVP, Chief HR OfficerPerformance Share UnitsGrant or awardDerivative units14,421Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
SVP, Chief HR OfficerStock Option (Right to Buy)Grant or awardDerivative units40,973Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
EVP & President, NeuroscienceOrdinary SharesExercise-price or tax withholding1,739$85.39 / share$148.49KJul 31Filed Aug 4 · 4d laterSEC filing
EVP & President, NeuroscienceOrdinary SharesGrant or award6,923Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
EVP & President, NeurosciencePerformance Share UnitsGrant or awardDerivative units17,306Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
EVP & President, NeuroscienceStock Option (Right to Buy)Grant or awardDerivative units49,167Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
EVP, GC and SecretaryOrdinary SharesGrant or award6,346Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
EVP, GC and SecretaryPerformance Share UnitsGrant or awardDerivative units15,863Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
EVP, GC and SecretaryStock Option (Right to Buy)Grant or awardDerivative units45,070Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
EVP & Chief Financial OfficerOrdinary SharesGrant or award11,537Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
EVP & Chief Financial OfficerPerformance Share UnitsGrant or awardDerivative units28,842Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
EVP & Chief Financial OfficerStock Option (Right to Buy)Grant or awardDerivative units81,945Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
EVP, Pres MedSurg and AmericasOrdinary SharesExercise-price or tax withholding3,356$85.39 / share$286.57KJul 31Filed Aug 4 · 4d laterSEC filing
EVP, Pres MedSurg and AmericasOrdinary SharesGrant or award10,960Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
EVP, Pres MedSurg and AmericasOrdinary SharesGrant or award46,147Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
EVP, Pres MedSurg and AmericasPerformance Share UnitsGrant or awardDerivative units27,400Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
EVP, Pres MedSurg and AmericasStock Option (Right to Buy)Grant or awardDerivative units77,848Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
EVP & President CardiovascularOrdinary SharesExercise-price or tax withholding3,074$85.39 / share$262.49KJul 31Filed Aug 4 · 4d laterSEC filing
EVP & President CardiovascularOrdinary SharesGrant or award9,230Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
EVP & President CardiovascularPerformance Share UnitsGrant or awardDerivative units23,074Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
EVP & President CardiovascularStock Option (Right to Buy)Grant or awardDerivative units65,556Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
Chairman and CEOOrdinary SharesExercise-price or tax withholding15,810$85.39 / share$1.35MJul 31Filed Aug 4 · 4d laterSEC filing
Chairman and CEOOrdinary SharesGrant or award41,533Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
Chairman and CEOPerformance Share UnitsGrant or awardDerivative units103,831Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
Chairman and CEOStock Option (Right to Buy)Grant or awardDerivative units295,002Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
Chairman and CEOStock Option (Right to Buy)Grant or awardDerivative units273,150Award · no purchase priceNon-cash awardAug 3Filed Aug 4 · 1d laterSEC filing
EVP, GC and SecretaryOrdinary SharesExercise-price or tax withholding2,069$86.88 / share$179.75KJul 28Filed Jul 29 · 1d laterSEC filing
SVP, Chief HR OfficerOrdinary SharesSale10b5-13,102$83.15 / share$257.93KJul 8Filed Jul 9 · 1d laterSEC filing
EVP & President CardiovascularOrdinary SharesSale2 trades4,189avg $80.44 / share$336.97KJun 8Filed Jun 9 · 1d later
2 filings
  • 3,961 @ $80.44 · $318.62KSEC filing
  • 228 @ $80.45 · $18.34KSEC filing
EVP & President CardiovascularOrdinary SharesExercise-price or tax withholding6,817$83.32 / share$567.99KJun 4Filed Jun 8 · 4d laterSEC filing
Chairman and CEOOrdinary SharesExercise-price or tax withholding41,936$83.32 / share$3.49MJun 4Filed Jun 8 · 4d laterSEC filing
EVP, Pres MedSurg and AmericasOrdinary SharesExercise-price or tax withholding7,471$83.32 / share$622.48KJun 4Filed Jun 8 · 4d laterSEC filing
SVP, Chief HR OfficerOrdinary SharesExercise-price or tax withholding2,840$83.32 / share$236.63KJun 4Filed Jun 8 · 4d laterSEC filing
Chief Accounting OfficerOrdinary SharesExercise-price or tax withholding237$83.32 / share$19.75KJun 5Filed Jun 8 · 3d laterSEC filing
SVP, Chief HR OfficerOrdinary SharesOption exercise or conversion9,149$0 reported · see filingNot establishedMay 26Filed May 28 · 2d laterSEC filing
SVP, Chief HR OfficerPerformance Share UnitOption exercise or conversionDerivative units8,449Exercise / conversion price not reportedNot a separate purchaseMay 26Filed May 28 · 2d laterSEC filing
EVP & Pres NeuroscienceOrdinary SharesOption exercise or conversion26,907$0 reported · see filingNot establishedMay 26Filed May 28 · 2d laterSEC filing
EVP & Pres NeurosciencePerformance Share UnitOption exercise or conversionDerivative units24,214Exercise / conversion price not reportedNot a separate purchaseMay 26Filed May 28 · 2d laterSEC filing
Chairman and CEOOrdinary SharesOption exercise or conversion94,963$0 reported · see filingNot establishedMay 26Filed May 28 · 2d laterSEC filing
Chairman and CEOPerformance Share UnitOption exercise or conversionDerivative units85,461Exercise / conversion price not reportedNot a separate purchaseMay 26Filed May 28 · 2d laterSEC filing
EVP, Pres MedSurg and AmericasOrdinary SharesOption exercise or conversion18,994$0 reported · see filingNot establishedMay 26Filed May 28 · 2d laterSEC filing
EVP, Pres MedSurg and AmericasPerformance Share UnitOption exercise or conversionDerivative units17,093Exercise / conversion price not reportedNot a separate purchaseMay 26Filed May 28 · 2d laterSEC filing
EVP & President CardiovascularOrdinary SharesOption exercise or conversion15,195$0 reported · see filingNot establishedMay 26Filed May 28 · 2d laterSEC filing
EVP & President CardiovascularPerformance Share UnitOption exercise or conversionDerivative units14,517Exercise / conversion price not reportedNot a separate purchaseMay 26Filed May 28 · 2d laterSEC filing
Chief Accounting OfficerOrdinary SharesOption exercise or conversion1,712$0 reported · see filingNot establishedMay 26Filed May 28 · 2d laterSEC filing
Chief Accounting OfficerPerformance Share UnitOption exercise or conversionDerivative units1,621Exercise / conversion price not reportedNot a separate purchaseMay 26Filed May 28 · 2d laterSEC filing
SVP, Chief HR OfficerOrdinary SharesExercise-price or tax withholding35$80.00 / share$2.8KMay 1Filed May 4 · 3d laterSEC filing
Chief Accounting OfficerOrdinary SharesGrant or award1,508Award · no purchase priceNon-cash awardApr 27Filed Apr 29 · 2d laterSEC filing
Chief Accounting OfficerOrdinary SharesExercise-price or tax withholding318$81.90 / share$26.04KApr 28Filed Apr 29 · 1d laterSEC filing
DirectorOrdinary SharesGrant or award2,111Award · no purchase priceNon-cash awardApr 27Filed Apr 29 · 2d laterSEC filing
DirectorOrdinary SharesExercise-price or tax withholding207$81.90 / share$16.95KApr 28Filed Apr 29 · 1d laterSEC filing
DirectorOrdinary SharesGrant or award2,111Award · no purchase priceNon-cash awardApr 27Filed Apr 29 · 2d laterSEC filing
DirectorOrdinary SharesExercise-price or tax withholding207$81.90 / share$16.95KApr 28Filed Apr 29 · 1d laterSEC filing
DirectorOrdinary SharesGrant or award2,111Award · no purchase priceNon-cash awardApr 27Filed Apr 29 · 2d laterSEC filing
DirectorOrdinary SharesExercise-price or tax withholding207$81.90 / share$16.95KApr 28Filed Apr 29 · 1d laterSEC filing
DirectorOrdinary SharesGrant or award2,111Award · no purchase priceNon-cash awardApr 27Filed Apr 29 · 2d laterSEC filing
DirectorOrdinary SharesExercise-price or tax withholding207$81.90 / share$16.95KApr 28Filed Apr 29 · 1d laterSEC filing
DirectorOrdinary SharesGrant or award1,803Award · no purchase priceNon-cash awardApr 27Filed Apr 29 · 2d laterSEC filing
DirectorOrdinary SharesGrant or award1,444Award · no purchase priceNon-cash awardApr 27Filed Apr 29 · 2d laterSEC filing
DirectorOrdinary SharesGrant or award2,111Award · no purchase priceNon-cash awardApr 27Filed Apr 29 · 2d laterSEC filing
DirectorOrdinary SharesExercise-price or tax withholding207$81.90 / share$16.95KApr 28Filed Apr 29 · 1d laterSEC filing
DirectorOrdinary SharesGrant or award1,444Award · no purchase priceNon-cash awardApr 27Filed Apr 29 · 2d laterSEC filing
DirectorOrdinary SharesGrant or award2,111Award · no purchase priceNon-cash awardApr 27Filed Apr 29 · 2d laterSEC filing
DirectorOrdinary SharesExercise-price or tax withholding207$81.90 / share$16.95KApr 28Filed Apr 29 · 1d laterSEC filing
DirectorOrdinary SharesGrant or award2,111Award · no purchase priceNon-cash awardApr 27Filed Apr 29 · 2d laterSEC filing
DirectorOrdinary SharesExercise-price or tax withholding207$81.90 / share$16.95KApr 28Filed Apr 29 · 1d laterSEC filing
DirectorOrdinary SharesGrant or award2,111Award · no purchase priceNon-cash awardApr 27Filed Apr 29 · 2d laterSEC filing
DirectorOrdinary SharesExercise-price or tax withholding207$81.90 / share$16.95KApr 28Filed Apr 29 · 1d laterSEC filing

Congress transactions 10

All Congress filings
Sale disclosed

Medtronic plc. Ordinary Shares (MDT) · Stock

The filing reports a sale for a joint account.

Kevin Hern official portraitKevin HernReporting House member
Reported amount
$15,001 – $50,000Reported range; exact amount not disclosed.
Trade date
August 24, 2026
Filed September 1, 2026 · 8d laterOriginal report
Sale disclosed

Medtronic plc. Ordinary Shares (MDT) · Stock

The filing reports a sale for the member.

Richard Dean Dr McCormick official portraitRichard Dean Dr McCormickReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
July 30, 2026
Filed August 14, 2026 · 15d laterOriginal report
Partial sale disclosedAmended report

Medtronic plc. Ordinary Shares (MDT) · Stock

The filing reports a partial sale for a joint account.

Julie Johnson official portraitJulie JohnsonReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
May 7, 2025
Filed August 5, 2026 · 455d laterOriginal report
Full sale disclosedAmended report

Medtronic plc. Ordinary Shares · Stock

The filing reports a full sale for a joint account.

Thomas H Tuberville official portraitThomas H TubervilleReporting Senate member
Reported amount
$15,001 – $50,000Reported range; exact amount not disclosed.
Trade date
August 26, 2024
Filed August 5, 2026 · 709d laterOriginal report
Purchase disclosed

Medtronic plc. Ordinary Shares · Stock

The filing reports a purchase for the member.

AAAlan ArmstrongReporting Senate member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
March 27, 2026
Filed July 21, 2026 · 116d laterOriginal report
Partial sale disclosed

Medtronic plc. Ordinary Shares (MDT) · Stock

The filing reports a partial sale for the member.

Gilbert Cisneros official portraitGilbert CisnerosReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
May 15, 2026
Filed June 8, 2026 · 24d laterOriginal report
Sale disclosed

Medtronic plc. Ordinary Shares (MDT) · Stock

The filing reports a sale for a joint account.

Kevin Hern official portraitKevin HernReporting House member
Reported amount
$15,001 – $50,000Reported range; exact amount not disclosed.
Trade date
March 20, 2026
Filed April 3, 2026 · 14d laterOriginal report
Sale disclosed

Medtronic plc. Ordinary Shares (MDT) · Stock

The filing reports a sale for a joint account.

Julie Johnson official portraitJulie JohnsonReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
December 18, 2025
Filed January 15, 2026 · 28d laterOriginal report
Partial sale disclosed

Medtronic plc. Ordinary Shares (MDT) · Stock

The filing reports a partial sale for a joint account.

Julie Johnson official portraitJulie JohnsonReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
November 13, 2025
Filed December 11, 2025 · 28d laterOriginal report
Purchase disclosed

Medtronic plc. Ordinary Shares (MDT) · Stock

The filing reports a purchase for the member.

Richard Dean Dr McCormick official portraitRichard Dean Dr McCormickReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
November 5, 2025
Filed December 9, 2025 · 34d laterOriginal report
Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0001613103
Latest public acceptance
Sep 17, 2026, 08:17 PM UTC
Score calculated
Oct 8, 2026, 12:08 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.